Viral suppression among adults with HIV receiving dolutegravir-based antiretroviral therapy and 3HP in Kampala, Uganda

被引:0
|
作者
Chaisson, L. [1 ]
Semitala, F. [2 ]
Dowdy, D. [3 ]
Aman, K. [4 ]
Steinmetz, S. [3 ]
Armstrong, D. [5 ]
Opira, B. [4 ]
Kamya, M. [2 ]
Phillips, P. [6 ]
Yoon, C. [6 ]
机构
[1] Univ Illinois, Med, Chicago, IL USA
[2] Makerere Univ, Coll Hlth Sci, Med, Kampala, Uganda
[3] Johns Hopkins Univ, Epidemiol, Baltimore, MD 21210 USA
[4] Infect Dis Res Collaborat, Kampala, Uganda
[5] Johns Hopkins Univ, Pathol, Baltimore, MD 21210 USA
[6] Univ Calif San Francisco, Med, San Francisco, CA 94132 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PESAB08
引用
收藏
页码:74 / 75
页数:2
相关论文
共 50 条
  • [1] Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine
    Chaisson, Lelia H.
    Semitala, Fred C.
    Nangobi, Florence
    Steinmetz, Samantha
    Marquez, Carina
    Armstrong, Derek T.
    Opira, Bishop
    Kamya, Moses R.
    Phillips, Patrick P. J.
    Dowdy, David W.
    Yoon, Christina
    AIDS, 2023, 37 (07) : 1097 - 1101
  • [2] Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda
    Byereta, Lillian Happy
    Olum, Ronald
    Mutebi, Edrisa Ibrahim
    Kalyesubula, Robert
    Kagimu, Majid
    Meya, David B.
    Andia-Biraro, Irene
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2024, 11
  • [3] Prevalence of and Factors Associated with Hypertension Among Adults on Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross Sectional Study
    Mutebi, Ronald Kasoma
    Semulimi, Andrew Weil
    Mukisa, John
    Namusobya, Martha
    Namirembe, Joy Christine
    Nalugga, Esther Alice
    Batte, Charles
    Mukunya, David
    Kirenga, Bruce
    Kalyesubula, Robert
    Byakika-Kibwika, Pauline
    INTEGRATED BLOOD PRESSURE CONTROL, 2023, 16 : 11 - 21
  • [4] The association between adherence to antiretroviral therapy and viral suppression under dolutegravir-based regimens: an observational cohort study from Uganda
    Wagner, Zachary
    Wang, Zetianyu
    Stecher, Chad
    Karamagi, Yvonne
    Odiit, Mary
    Haberer, Jessica E.
    Linnemayr, Sebastian
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 (08)
  • [5] Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
    Nakatudde, Irene
    Katana, Elizabeth
    Agnes Odongpiny, Eva Laker
    Nalugga, Esther Alice
    Castelnuovo, Barbara
    Fowler, Mary Glenn
    Musoke, Philippa
    AIDS RESEARCH AND THERAPY, 2024, 21 (01)
  • [6] Pharmacokinetics and HIV viral load suppression of 1 month-daily rifapentine and isoniazid (1HP) for tuberculosis preventive therapy among adults with HIV taking standard dolutegravir-based regimens
    Avihingsanon, A.
    Jirajariyavej, S.
    Ayuthaya, T. Palakawong Na
    Treebupachatsakul, P.
    Sophonphan, J.
    Visuthranukul, J.
    Danpornprasert, D.
    Imsanguan, W.
    Panarat, P.
    Wiwatrojanagul, S.
    Noopetch, P.
    Natcha, N.
    Gatechompol, S.
    Lwin, H. S.
    Thammapiwan, S.
    Pingsusaen, P.
    Kerr, S. J.
    Shin, J. -G.
    Chetchotisakd, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 12 - 12
  • [7] Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Cheng, Aristine
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Lin, Kuan-Yin
    Huang, Yi-Chia
    Liu, Wen-Chun
    Wu, Pei-Ying
    Hung, Chien-Ching
    Chang, Shan-Chwen
    MEDICINE, 2019, 98 (26)
  • [8] Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants
    Vianney John Kigongo
    Joaniter I. Nankabirwa
    Freddy Eric Kitutu
    Ronald Ssenyonga
    Ronald Kasoma Mutebi
    Andrew Kazibwe
    Ronald Kiguba
    Andrew D. Kambugu
    Barbara Castelnuovo
    BMC Infectious Diseases, 24
  • [9] Dyslipidemia among adult people living with HIV on dolutegravir - based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants
    Kigongo, Vianney John
    Nankabirwa, Joaniter I.
    Kitutu, Freddy Eric
    Ssenyonga, Ronald
    Mutebi, Ronald Kasoma
    Kazibwe, Andrew
    Kiguba, Ronald
    Kambugu, Andrew D.
    Castelnuovo, Barbara
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana
    Bareng, Ontlametse T.
    Moyo, Sikhulile
    Mudanga, Mbatshi
    Sebina, Kagiso
    Koofhethile, Catherine
    Choga, Wonderful
    Gobe, Irene
    Motswaledi, Modisa
    Maruapula, Docas
    Moraka, Natasha
    Musonda, Rosemary
    Nkomo, Joseph
    Ramaabya, Dinah
    Chebani, Tony
    Makuruetsa, Penny
    Makhema, Joseph
    Gaseitsiwe, Simani
    BMJ GLOBAL HEALTH, 2023, 8 (SUPPL_10): : A24 - A24